Get the latest Science News and Discoveries

Ficlatuzumab plus chemotherapy may benefit patients with relapsed/refractory AML


None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of AML

AML

Related news:

News photo

Oncotarget: Activation of plasmacytoid dendritic cells promotes AML-cell fratricide

News photo

Investigational combo therapy shows benefit for TP53 mutant MDS and AML patients

News photo

New drug combination shows promise as powerful treatment for AML